Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Share of Common Stock - Schedule of Antidilutive Securities Excluded from Computation of Diluted Weighted Average Shares Outstanding (Detail)

v3.22.2.2
Net Loss Per Share of Common Stock - Schedule of Antidilutive Securities Excluded from Computation of Diluted Weighted Average Shares Outstanding (Detail) - shares
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potentially antidilutive securities outstanding excluded from the computation of diluted weighted average shares 13,840,943 13,877,284
Employee Stock Options [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potentially antidilutive securities outstanding excluded from the computation of diluted weighted average shares 4,515,422 2,950,551
Warrants [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potentially antidilutive securities outstanding excluded from the computation of diluted weighted average shares 9,325,521 10,926,733